Effectiveness and safety of switching biologics after secukinumab treatment failure in moderate-to-severe plaque psoriasis: a retrospective cohort study - Quiz - MDSpire

Effectiveness and safety of switching biologics after secukinumab treatment failure in moderate-to-severe plaque psoriasis: a retrospective cohort study

  • By

  • Zhongyu Zhang

  • Bin Zhang

  • Yating Wen

  • Qian Hu

  • Wenjun Jiang

  • Jia Zhuo

  • Guangying Luo

  • Yuyi Wang

  • July 6, 2026

  • 0 min

Share

Original Source(s)

Effectiveness and safety of switching biologics after secukinumab treatment failure in moderate-to-severe plaque psoriasis: a retrospective cohort study

  • by Zhongyu Zhang, Bin Zhang, Yating Wen, Qian Hu, Wenjun Jiang, Jia Zhuo, Guangying Luo, Yuyi Wang

  • July 6, 2026

Related Content

GLP-1 RAs May Ease Psoriasis, PsA Data Limited

Published evidence linked liraglutide and semaglutide to improvements in psoriasis severity, inflammatory markers, and metabolic outcomes, while evidence in psoriatic arthritis remained sparse.

Dermatologic Conditions and Incident Anxiety in Young Adults: Propensity Score–Matched Retrospective Cohort Study

Early Response to Calcipotriol and Betamethasone Dipropionate PAD-Cream at Week 4 in Patients with Mild-to-Moderate Plaque Psoriasis: A Post-Hoc Pooled Analysis of Two Phase III Trials